| Literature DB >> 30311574 |
Abstract
Cancer stem cells (CSCs; also known as tumor-initiating cells) are a small population of cancer cells that retain characteristics similar to those of normal stem cells. CSCs are known to be responsible for metastasis, drug resistance, and cancer recurrence. Thus, controlling CSCs may provide an effective therapeutic intervention that inhibits tumor growth and aggressiveness. Despite the importance of targeting CSCs in cancer therapy, the detailed nature of oral CSCs remains underexplored. This article reviews the current understanding of oral CSCs, with emphasis on recent advances in novel signaling pathways involved in their stemness regulation.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30311574 PMCID: PMC6436811 DOI: 10.1615/CritRevOncog.2018027501
Source DB: PubMed Journal: Crit Rev Oncog ISSN: 0893-9675